期刊文献+

子宫内膜异位症患者血管内皮生长因子的检测及其临床意义 被引量:3

Determination of vascular endothelial growth factor in patients with endometriosis and its clinical significance
下载PDF
导出
摘要 目的 旨在探讨血管内皮生长因子(VEGF)在子宫内膜异位症(EM)发病机制中的作用,并初步探讨VECG在EM中的诊断价值。方法 采用定量双抗体夹心酶联免疫吸附法(ABC-ELISA)测定44例EM患者(Ⅰ~Ⅱ期10例,Ⅲ期20例、Ⅳ期14例),20例对照组和18例术后经孕三烯酮治疗3个月的EM患者腹腔液和血清中VEGF的浓度。分析EM患者腹腔液中VEGF与EMr-AFS分期的关系,并比较VEGF在血清、腹腔液中的含量,同时利用ROC曲线初步分析其诊断EM的灵敏度和特异性。结果 ①EM患者腹腔液中VEGF浓度显著高于对照组(P〈0.05);VEGF浓度在EM患者Ⅰ~Ⅱ期和Ⅲ期、Ⅳ期比较差异均无统计学意义(P〉0.05);ⅡEM患者血清中VEGF浓度高于复查组,差异有统计学意义(P〈0.05);③ROC曲线发现,EM患者腹腔液中VEGF浓度对EM的诊断具有一定价值。结论 VEGF在EM的发病机制中可能发挥着重要作用,抗血管生成治疗方法有望成为EM新的治疗策略和靶点。 Objective To determine the role of vascular endothelial growth factor (VEGF) in the pathogenesis of endometriosis (EM) and to evaluate its diagnostic values. Methods The level of VEGF in peritoneal fluid (PF) and serum was measured using enzyme linked immunosorbent assay (ELISA) from 44 women with EM (stage Ⅰ , Ⅱ n = 10,stage Ⅲ n =20,stage Ⅳ n = 14) and without EM (control group n =20) as well as progestin-treated group postoperatively for 3 months ( n = 18). The relation of VEGF in PF to EM and r-AFS was analysed,and the VEGF concentration in PF and serum were compared. At the same time, receiver operator characteristic curve (ROC) was used to analyze the sensitivity and specificity of VEGF in PF for diagnois the EM. Results ①The VEGF level in PF of EM patients was higher compared to control group (P〈 0.05) ;②The VEGF level in serum of EM patients was significantly higher compared to counterhack group (P 〈 0.05) ; ③VEGF in PF is helpful for diagnosis the EM. Conclusion These data suggest that VEGF may play an important role in the pathogenesis ot EM. The tree of angiogenesis inhibitor may provide a novel therapeutic approach for treating the EM.
出处 《山西医药杂志》 CAS 2006年第6期500-502,共3页 Shanxi Medical Journal
关键词 子宫内膜异位症 内皮生长因子 血管 血清学 腹水液 Endometfiosis Endothelial growth factor,vascular Serology Ascitic fluid
  • 相关文献

参考文献7

二级参考文献29

  • 1-.-[J].国外医学妇产学科分册,2001,28(1):40-40.
  • 2Kraft A,Weindel K,Ochs A,et al.Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.Cancer,1999,85(1):178
  • 3Neufeld G,Cohen T,Gengrinovitch S,et al.Vascular endothelial growth factor(VEGF)and its receptors.FASEB J,1999,13(1):9
  • 4Oyama T,Ran S,Ishida T,et al.Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells.J Immunol,1998,160(3):1224
  • 5Abulafia O,Triest WE,Sherer DM.Angiogenesis in malignancies of the female genital tract.Gynecol Oncol,1999,72(2):220
  • 6Oehler MK,Caffier H.Diagnostic value of serum VEGF in women with ovarian tumors.Anticancer Res,1999,19(4):2519
  • 7Perez RM,Ros J,Morales RM,et al.Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients:regulation by cytokines and bacterial lipopolysaccharide.Hepatology,1999,29(4):1057
  • 8Obermair A,Tempfer C,Hefler L,et al.Concentration of vascular endothelial growth factor(VEGF)in the serum of patients with suspected ovarian cancer.Br J Cancer,1998,77(11):1870
  • 9Fujishita A, Hasuo A, Khan KN, et al. Gynecol Obstet Invest,1999, 48 [Suppl 1]:36-44
  • 10Ota H, Igarashi S, Hatazawa J, et al. Hum Reprod Update,1998, 4(4): 360-367

共引文献9

同被引文献12

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部